Organisation paid for research Program year 2025 Source: CMS Open Payments

Bexley Dermatology

Neither a doctor nor a teaching hospital

Research payments

$77,622

711 payments

Through program year 2025, Bexley Dermatology is reported as receiving $77,622 in research payments, across 711 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$15,350	290
2024	Research	$53,606	345
2023	Research	$4,767	38
2022	Research	$3,899	38

Breakdown

Who paid Research payments · program years 2022–2025

Incyte Corporation $77,622 711 payments

Studies the money was for Research payments · program years 2022–2025

A Phase 2, Double-Blind, Randomized, 16-Week, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Open-Label Extension Period in Adults With Chronic Hand Eczema $37,595 48 payments
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa $19,510 312 payments
A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa $9,835 177 payments
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa $5,514 113 payments
A Randomized, Double-Blind, Vehicle-Controlled Study of the Efficacy and Safety of Ruxolitinib Cream in Participants With Cutaneous Lichen Planus $3,899 38 payments
A Study to Evaluate the Long-Term Safety and Efficacy of Povorcitinib in Participants With Moderate to Severe Hidradenitis Suppurativa $1,268 23 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.